Dexmedetomidine protects H9C2 rat cardiomyocytes against hypoxia/reoxygenation injury by regulating the long non-coding RNA colon cancer-associated transcript 1/microRNA-8063/Wnt/β-catenin axis

References

• Hou L, Guo J, Xu F, et al. Cardiomyocyte dimethylarginine dimethylaminohydrolase1 attenuates left-ventricular remodeling after acute myocardial infarction: involvement in oxidative stress and apoptosis. Basic Res Cardiol. 2018;113(4):28.
   PubMed Web of Science ®Google Scholar
• Heusch G. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol. 2020;17(12):773–789.
   PubMed Web of Science ®Google Scholar
• Yang M, Linn BS, Zhang Y, et al. Mitophagy and mitochondrial integrity in cardiac ischemia-reperfusion injury. Biochimica et biophysica acta Mol basis dis. 2019;1865(9):2293–2302.
   PubMed Web of Science ®Google Scholar
• Kuznetsov AV, Javadov S, Margreiter R, et al.The role of mitochondria in the mechanisms of cardiac ischemia-reperfusion injury.Antioxidants. Basel, Switzerland.2019;85:454.
   Web of Science ®Google Scholar
• Marin W, Marin D, Ao X, et al. Mitochondria as a therapeutic target for cardiac ischemia‑reperfusion injury (Review). Int J Mol Med. 2021;47(2):485–499.
   PubMed Web of Science ®Google Scholar
• Shi X, Liu Z, Li J. Protective effects of dexmedetomidine on hypoxia/reoxygenation injury in cardiomyocytes by regulating the CHOP signaling pathway. Mol Med Rep. 2020;22(4):3307–3315.
   PubMed Web of Science ®Google Scholar
• Singhanat K, Apaijai N, Jaiwongkam T, et al. Melatonin as a therapy in cardiac ischemia-reperfusion injury: potential mechanisms by which MT2 activation mediates cardioprotection. J Adv Res. 2021;29:33–44.
   PubMed Web of Science ®Google Scholar
• Manning JR, Thapa D, Zhang M, et al. Loss of GCN5L1 in cardiac cells disrupts glucose metabolism and promotes cell death via reduced Akt/mTORC2 signaling. Biochem J. 2019;476(12):1713–1724.
   PubMed Web of Science ®Google Scholar
• Kong W, Kang K, Gao Y, et al. Dexmedetomidine alleviates LPS-induced septic cardiomyopathy via the cholinergic anti-inflammatory pathway in mice. Am J Transl Res. 2017;9(11):5040–5047.
   PubMed Web of Science ®Google Scholar
• Wang C, Yuan W, Hu A, et al. Dexmedetomidine alleviated sepsis‑induced myocardial ferroptosis and septic heart injury. Mol Med Rep. 2020;22(1):175–184.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Ling X, Zhou H, et al. Dexmedetomidine at a dose of 1 µM attenuates H9c2 cardiomyocyte injury under 3 h of hypoxia exposure and 3 h of reoxygenation through the inhibition of endoplasmic reticulum stress. Exp Ther Med. 2021;21(2):132.
   PubMed Web of Science ®Google Scholar
• Yin W, Wang C, Peng Y, et al. Dexmedetomidine alleviates H(2)O(2)-induced oxidative stress and cell necroptosis through activating of α2-adrenoceptor in H9C2 cells. Mol Biol Rep. 2020;47(5):3629–3639.
   PubMed Web of Science ®Google Scholar
• Zampetaki A, Albrecht A, Steinhofel K. Long non-coding RNA structure and function: is there a link? Front Physiol. 2018;9:1201.
   PubMed Web of Science ®Google Scholar
• Guo X, Hua Y. CCAT1: an oncogenic long noncoding RNA in human cancers. J Cancer Res Clin Oncol. 2017;143(4):555–562.
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang W, Lin J, et al. lncRNA CCAT1 promotes bladder cancer cell proliferation, migration and invasion. Int braz j urol. 2019;45(3):549–559.
   PubMed Web of Science ®Google Scholar
• Li JL, Li R, Gao Y, et al. LncRNA CCAT1 promotes the progression of preeclampsia by regulating CDK4. Eur Rev Med Pharmacol Sci. 2018;22(5):1216–1223.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Chen Q, Wan L, et al. Dexmedetomidine protects hepatic cells against oxygen-glucose deprivation/reperfusion injury via lncRNA CCAT1. Cell Biol Int. 2018;42(9):1250–1258.
   PubMed Web of Science ®Google Scholar
• Wang Z, Yang Y, Xiong W, et al. Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis. Biomed Pharmacothe. 2020;125:110001.
   PubMed Web of Science ®Google Scholar
• Wang Z, Yang Y, Xiong W, et al. Corrigendum to “Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis” [Biomed. Pharmacother. 125 (2020) 110001]. Biomed Pharmacothe. 2020;130(130):110841.
   PubMed Web of Science ®Google Scholar
• Liu K, Zhao D, Wang D. LINC00528 regulates myocardial infarction by targeting the miR-143-3p/COX-2 axis. Bioengineered. 2020;11(1):11–18.
   PubMed Web of Science ®Google Scholar
• Gao H, Jiang J, Shi Y, et al. The LINC00477/miR-128 axis promotes the progression of polycystic ovary syndrome by regulating ovarian granulosa cell proliferation and apoptosis. ReprodBiol Endocrinol. 2021;19(1):29.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhu Q, Lu L, et al. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1. Bioengineered. 2020;11(1):91–102.
   PubMed Web of Science ®Google Scholar
• Pan G, Mao A, Liu J, et al. Circular RNA hsa_circ_0061825 (circ-TFF1) contributes to breast cancer progression through targeting miR-326/TFF1 signalling. Cell Prolif. 2020;53(2):e12720.
   PubMed Web of Science ®Google Scholar
• Wang G, Bai X, Jiang G, et al. GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma. Bioengineered. 2021;12(1):30–43.
   PubMed Web of Science ®Google Scholar
• Nie S, Cui X, Guo J, et al. Long non-coding RNA AK006774 inhibits cardiac ischemia-reperfusion injury via sponging miR-448. Bioengineered. 2021;12(1):4972–4982.
   PubMed Web of Science ®Google Scholar
• Liang H, Su X, Wu Q, et al. LncRNA 2810403D21Rik/Mirf promotes ischemic myocardial injury by regulating autophagy through targeting Mir26a. Autophagy. 2020;16(6):1077–1091.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang Y, Ding N, et al. Inhibition of lncRNA XIST improves myocardial I/R injury by targeting miR-133a through inhibition of autophagy and regulation of SOCS2. Mol Ther Nucleic Acids. 2019;18:764–773.
   PubMedGoogle Scholar
• Hu YH, Sun J, Zhang J, et al. Long non-coding RNA ROR sponges miR-138 to aggravate hypoxia/reoxygenation-induced cardiomyocyte apoptosis via upregulating Mst1. Exp Mol Pathol. 2020;114:104430.
   PubMed Web of Science ®Google Scholar
• Wang L, Liu W, Zhang Y, et al. Dexmedetomidine had neuroprotective effects on hippocampal neuronal cells via targeting lncRNA SHNG16 mediated microRNA-10b-5p/BDNF axis. Mol Cell Biochem. 2020;469(1–2):41–51.
   PubMed Web of Science ®Google Scholar
• Ta Na HS, An M, Zhang T, et al. Dexmedetomidine inhibits microglial activation through SNHG14/HMGB1 pathway in spinal cord ischemia-reperfusion injury mice. Int J Neurosci. 2022;132(1):77–88.
   PubMed Web of Science ®Google Scholar
• Chen ZX, He D, Mo QW, et al. MiR-129-5p protects against myocardial ischemia-reperfusion injury via targeting HMGB1. Eur Rev Med Pharmacol Sci. 2020;24(8):4440–4450.
   PubMed Web of Science ®Google Scholar
• Huang ZQ, Xu W, Wu JL, et al. MicroRNA-374a protects against myocardial ischemia-reperfusion injury in mice by targeting the MAPK6 pathway. Life Sci. 2019;232:116619.
   PubMed Web of Science ®Google Scholar
• Wang LX, Wan C, Dong ZB, et al. Integrative analysis of long noncoding RNA (lncRNA), microRNA (miRNA) and mRNA expression and construction of a competing endogenous RNA (ceRNA) network in metastatic melanoma. Med Sci Monit. 2019;25:2896–2907.
   PubMed Web of Science ®Google Scholar
• Luan X, Wang Y. LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p. J Gynecol Oncol. 2018;29(6):e95.
   PubMed Web of Science ®Google Scholar
• Du J, Yang ST, Liu J, et al. Silence of LncRNA GAS5 protects cardiomyocytes H9c2 against hypoxic injury via sponging miR-142-5p. Mol Cells. 2019;42(5):397–405.
   PubMed Web of Science ®Google Scholar
• Schunk SJ, Floege J, Fliser D, et al. WNT-β-catenin signalling - a versatile player in kidney injury and repair. Nat Rev Nephrol. 2021;17(3):172–184.
   PubMed Web of Science ®Google Scholar
• Garriock RJ, Warkman AS, Meadows SM, et al. Census of vertebrate Wnt genes: isolation and developmental expression of Xenopus Wnt2, Wnt3, Wnt9a, Wnt9b, Wnt10a, and Wnt16. Dev Dyn. 2007;236(5):1249–1258.
   PubMed Web of Science ®Google Scholar
• Działo E, Tkacz K, Błyszczuk P. Crosstalk between the TGF-β and WNT signalling pathways during cardiac fibrogenesis. Acta Biochim Pol. 2018;65(3):341–349.
   PubMed Web of Science ®Google Scholar
• Działo E, Rudnik M, Koning RI, et al. WNT3a and WNT5a transported by exosomes activate WNT signaling pathways in human cardiac fibroblasts. Int J Mol Sci. 2019;20(6):1436.
   PubMed Web of Science ®Google Scholar
• Yan G, Wang J, Fang Z, et al. MiR-26a-5p targets WNT5A to protect cardiomyocytes from injury due to hypoxia/reoxygenation through the Wnt/β-catenin signaling pathway. Int Heart J. 2021;62(5):1145–1152.
   PubMed Web of Science ®Google Scholar
• Tang T, Guo C, Xia T, et al. LncCCAT1 promotes breast cancer stem cell function through activating WNT/β-catenin signaling. Theranostics. 2019;9(24):7384–7402.
   PubMed Web of Science ®Google Scholar
• Chen ZQ, Yuan T, Jiang H, et al. MicroRNA‑8063 targets heterogeneous nuclear ribonucleoprotein AB to inhibit the self‑renewal of colorectal cancer stem cells via the Wnt/β-catenin pathway. Oncol Rep. 2021;45(4):46.
   PubMed Web of Science ®Google Scholar
• Huang Y. The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases. J Cell Mol Med. 2018;22(12):5768–5775.
   PubMed Web of Science ®Google Scholar